Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this study is to determine whether patients undergoing coronary intervention that also require oral anticoagulation, treatment with the COBRA PzF stent plus 14-day dual anti-platelet therapy (DAPT) has higher safety and non-inferior outcomes for thrombo-embolic events than compared with standard FDA-approved drug eluting stent (DES) plus 3 or 6-month DAPT.
Epistemonikos ID: 16d4f3bf93e594ead7fd1196b9fa1f1ea3be48bf
First added on: May 12, 2024